Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It certainly seems that the Volume has slowed considerably...been more than a week since we have seen 10M. At least it appears for the moment that everyone is waiting for the next PR to come out before making that next decision...even the Manipulators are holding off.
I hope it is the lull before the storm...waiting for that major "Breakthrough" announcement to come out any day now...that and the 10-K! Something has to happen within the next 3 buisness days...Hopefully like Sol has been stating when he is not bashing. "one PR could double or triple the PPS"
In My Own Opinion Of Course!
Long AMBS!
Tanis, I sure hope your right.
I too believe that a major JV/Partner is going to be announced any day on one of the products in the pipeline.
But what I am guessing....again, strictly a guess is that the 10-K is going to show that all 1B shares have been issued, and that alone will be the reason it has been delayed 15 days...trying to finalize the deal with what ever partner(IPXL?)so that the "Big Joint Venture" can be released in conjunction with the annual filing...try to soften the blow of seeing all 1B shares issued.
Lets hope I'm wrong!!!
Of Course In My Opinion Only!
Long AMBS!
And I thought the expectations of utilizing Eltoprazine were to decrease Levodopa-induced dyskinesia(LID) in the treatment of Parkinson's disease. If the goal is to reduce or eliminate the hyperkinetic movements associated with the disease, would AMBS actually consider licencing Dipraglurant to add to their pipeline? Seeing how the side effects are pretty awful themselves, would one rather be shaking... or nearly incapacitated and not shaking?
Still no 10-K posted as of yet? Looks like GC and company will only have one more week to delay the posting now. Seeing how 15th is the deadline and that is now one week away...
Sure hope it is being delayed for a goooooooood reason!
Long AMBS!
Taken straight from the latest 10K.....
Thanks BigFoot,
I didn't get an order in place today, but may start a position tomorrow or in the near future. At the price, it really seems appetizing to to pick up a few Mill, but with the uncertantity of financing and the decreasing PPS, I may just stick to 1 for now and watch for future opportunities. Hopefully this PR that is mentioned for tomorrow will be good news?
GLTA
Hopefully this is just the beginning of the media relations that GC and the AMBS crew has in store for the future of LymPro. Just trying to find out what questions and concerns a small sample of the general public may have, so that they will have all the proper responses to any and all questions that may arise when standing behind a podium answering questions to the World!
Looking at the SAR, the downward momentum has touched bottom and leveled out...could the positive days be ahead? Lets move this baby back to the green and keep accumulating while the price is affordable.
In My Personal Opinion Of Course!
Long AMBS!
Thanks for the DD, I am new to this stock, and interested in picking up a few shares, but can not find any 10K since 2009...and it mentions a lot of debt, and lawsuit. Is there anything newer than that out there? If so, does someone have a copy, or anything regarding their financials? I see that they have over 3.4 Billion shares outstanding at this time, is there any mention of a reverse split in their future? I also see mention of company updates and future FDA approvals. Maybe things will get rolling then? But, if anyone can shed some light, I would greatly appreciate it.
Did I miss a PR stating that the Phase 2B studies have commenced on both LID and ADHD?
That and the fact that his first mentioned company mentioned under Freqent and intensive interactions is...get ready Blackhawks...Novartis! Could that be a coincidence???
I Sure Hope So, JP!
It is time to retire these Red Glasses and put the Green ones back on!
Watching the PPS bleed for the past two months has certainly been disheartening, but I too believe in the company and what GC has been doing. Feeling like a kid at Christmas waiting for the next PR to be something exciting!
Long AMBS!
That would be great news...and especially if the QP name rhymes with "Cavendish"! Love all the DD and Specualations going on here! Just counting down the days till Q2 arrives!!
Bought another 25K today!
Long AMBS!
Very Well Said!
Long AMBS!
Very well said!
The AMBS Board of Directors, Researchers, and Scientitsts all behind MANF, and the entire pipeline are all doing great work. It is only a matter of time until this whole thing explodes!
My guess is that Alapis doesnt hold any shares at all, either that or he bought in when it was at .13 and doesn't have the money to invest in other companies until AMBS does skyrocket. I guess I would be upset too if I made a bad decision and my funds were all tied up. Only consolation I can add is that it will all work out in the end. Even those who bought in late will be hansomely rewarded when the news starts to break.
The $20M promise from LPC was only a facade to allow AMBS more leverage to attract bigger and better deals from all those who were courting. GC did a great thing by seeking a deal that only cost the company 4M Shares at .10 IMO the other $19.6M will never be needed because the "Big Deal" will be made public soon, and even LPC will be able to cash out on their small helping hand in making AMBS an even more attractive Company!
My hats off to GC and the entire AMBS team! Well Played Sir!
I believe Great news will be breaking very soon!
Patience Alapis...Patience!
As Always, In My Own Opinion!
Long AMBS!
Everything on this list points to 2014 being the Break Out Year!!!
If all of these milestones truely make it, it should be a very exciting year indeed!
Just keep loading up on the shares while the price is down, because it will not stay there for long.
Just one news release about starting a Phase 2B Trial for Eltoprazine for in Levadopa-Induced Dyskynesia (PD LID), a news release about starting a Phase 2B trial in Adult ADHD, or results from the Lympro study to support CLIA, and the price will most likely double every day. And seeing how about half of the milestones are First Half of 2014, and the first three months are over....
Almost seems like the Birth of something Wonderful over the next 9 months!
Gooooooo GC, and Goooooooo AMBS!
In My Opinon Of Course...
Long AMBS!
So, does the recent buy back of old warrants, and the new $20M LPF Deal cover the $1M necessary to pay off the Milestone payment to Memory once the Phase II study is released?
Is this what GC has been waiting on for the funding? Hmmmmm?
CLIA Work was supposed to start 3Q-2013...should be about finished if that is the case...Time to start making money!
Amarantus paid Memory Dx 2.0 million shares of common stock, and will pay a royalty equal to 9% of the net proceeds of all sales resulting from the license. Amarantus will fund the validation study for LymPro, and as has agreed to pay $50,000 to prepare the laboratory for the necessary CLIA work, which we expect to begin in the third quarter of 2013. Memory Dx LLC is entitled to a $1.0 million milestone payment (in cash or stock) upon the successful completion of the phase II validation study, facilitating commercial sale of the product as an "aid to the diagnosis of Alzheimer's disease."
In my Opinion Of Course...
.075 looks like pretty stable ground!
Keep loading up and watch the momentum start to swing in the other direction! I have seen more buying today than I have seen in the past few weeks, may be a sign of better things about to break? Some insiders know literature and milestones are about to be released? Some private investors know partnerships are about to be formed? And all of us on this board know that the Financing deal carried us over a major dilutive hurdle!
Call it a party, or call it a Luau, I am loading as much as I can before this ship leaves this Sub $.10 Island and never returns!
Long AMBS!
Really appreciate all the Charts, especially the weekly ones. I agree that something major is brewing. Unfortunately I don't think too much can be taken from the charts prior to reorganization in Late 2012/Early 2013. But from then on, it has been a wild ride. (Except for the dip around April 13)
Just looking at the company from the past One year, GC has done an amazing job of building a very talented group who will succeed at building a lasting revenue generating company. From his scientific advisors to his technology and buisness advisors, he has true leaders from top to bottom!
Our 200 Day MA has been increasing steadily from September 2013, and the 50 Day MA has been doing the same. Apart from the Major Manipulation over the past couple weeks, things have been nothing but positive.
The $20M with Lincoln Park WILL take us to new heights, but it is also going to take some new info and positive press releases on the part of the Company. It has been no Secret that GC wants to get off of the OTC, and get uplisted ASAP, and with all the afore mentioned milestones in his Blogs, it can only be a matter of months or even weeks from now... First Quarter is coming to a close, and 2nd Qtr will be here in less than 2 weeks! The promised...."Promise Land" shall be upon us all soon!
All the Longs need to be patient in this down time where the manipulation is heavy. If you can afford, load up on the dips because there is a lot of support at this .075 level...buy what the shorts are unloading, and they will be sorry in a month or two!
IN MY OPINION, the Rewards will be plentiful in the coming months!
Good Luck to All!
I would have to agree Risk...No positive news regarding LymPro is driving down the PPS, and the only ones smiling are the Manipulators and Day Traders. Those of us holding for the future may be left holding empty bags if GC doesn't put out some good news soon!
Afterall, here we are about to close on Q1-14, and where are the results that are expected from the LymPro studies that are supposed to take us to a LDT through CLIA? Do we have something to submit to CLIA? When will we have something to submit if we are expecting commercialization in 2014? Come on AMBS, give us some News!
Corporate Profile
1 week, 3 weeks, a month...all "Later this Year".
I was not implying that it is going to happen immediately, rather made an inference that I do not see any other possibilities. Nothing else in the AMBS pipeline ready to "Happen" other than continuation of studies.
With the uncertanity that GC faced regarding financing the Studies without a JV partner...let alone financing the company for the forseeable future. MY OPINION ONLY...He had to state "Later this year".
Honestly I am glad that AMBS didn't employ someone any sooner to work with on the continuation of the studies..leaves less hands in the "Cookie Jar" when it comes time to make buy-outs from a Major Pharm Company to sell the end product(s). AMBS has done very well to build a reputation by surrounding itself with big name Execs from other very successful companies, and it is very apparant that GC wants to maximize the profits for AMBS only, and not share with a lot of different partners.
But now that the financing deal is completed...(Insert your own speculations here)...will happen "later this year".
Again, IMO...
but welcome any other thoughts???
New to the site, enjoy the posts, and long on AMBS!
I too would like to offer up my thoughts...
We who are holding Tens of thousands if not Millions of shares are very excited about the news of financing. And awaiting some big news from GC.
With all the new Orphans in the rough, and only Eltoprazine in current studies, I believe the next major announcement will be a Phase 2B study for PD LID or Adult ADHD...IMO
I don't see anything else that could be close for news.
(Taken from the Q1-2014: The Maturation of Amarantus
Posted on Monday, February 24th, 2014 at 9:46 am"
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
2.Eltoprazine is expected to be entering Phase 2b later this year in Levadopa-Induced Dyskynesia (PD LID), an indication with revenue potential in excess of $750M per year in the United States alone. In addition, the Company has the opportunity to initiate a Phase 2b trial in Adult ADHD, where there is a growing need for non-scheduled, non-stimulant-based treatments. Importantly, Eltoprazine has been evaluated in over 700 patients to date, and has a very strong safety profile thereby mitigating commercial safety risk for potential partners;
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Just my thoughts...afterall, it is "Later this year"???
Time to start enrolling patients!!!
Anyone else?